Consolidated Statement Of Income And Comprehensive Income | |
Net sales | 777M |
Cost of goods sold | 430.73M |
Research and development expenses | 64.42M |
Selling and administrative expenses | 152.05M |
Restructuring and other charges, net | 0 |
Interest expense | 13.11M |
Other expense, net | -2.16M |
Total cost and expense | |
Income before taxes on income | 113.39M |
Taxes on income | 23.61M |
Net income | 89.78M |
Other comprehensive income: | |
Foreign currency translation adjustments | |
Gains (Losses) on derivatives qualifying as hedges | |
Pension and postretirement net liability adjustment | |
Comprehensive income | 86.44M |
Net income per share - basic | 1.13 |
Net income per share - diluted | 1.12 |
Average number of shares outstanding - basic | 79.58M |
Average number of shares outstanding - diluted | 79.94M |
Dividends declared per share | 0.64 |